Last updated: 4 months ago
PolyPid Ltd. Reports $14.5M Private Placement Offering to Fuel Clinical Trials
Explore PolyPid Ltd.'s Form 6-K detailing a $14.5M private placement to support SHIELD II Phase 3 trials, with potential additional $27M from warrants. Key financial insights included.